دوا کے تعاملات
Certolizumab pegol + Ciltacabtagene autoleucel
شدت: شدید
Certolizumab pegol and Ciltacabtagene autoleucel: major interaction.
آخری تازہ کاری
صرف صحت کے پیشہ ور افراد کے لیے — محض حوالے کے طور پر۔ یہ صفحہ مختصر خلاصہ ہے، طبی مشورہ نہیں، اور سرکاری لیبل یا طبی فیصلے کا متبادل نہیں۔ تجویز یا فراہمی سے پہلے ہمیشہ تصدیق کریں۔
اس صفحے کا طبی مواد صرف انگریزی میں دستیاب ہے۔
خلاصہ
Certolizumab pegol blocks TNF and causes immunosuppression, while ciltacabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and hypogammaglobulinemia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
اس تعامل کا آسان لفظوں میں مطلب
Certolizumab pegol and Ciltacabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Certolizumab pegol belongs to Musculoskeletal; Ciltacabtagene autoleucel belongs to Miscellaneous.
ایسا کیوں ہوتا ہے
Additive immunosuppression from TNF blockade and CAR-T related lymphodepletion and cytopenias.
کیا کرنا ہے
Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
فارماسسٹ سے کیا پوچھیں
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ اراکین کے لیے
پورا صفحہ کھولیں
Certolizumab pegol اور Ciltacabtagene autoleucel کے لیے مکمل طبی انتظام کی رہنمائی، اضافی نوٹس، شواہد کی تفصیل اور پورے نسخے کا تعامل چیکر کھولنے کے لیے اکاؤنٹ بنائیں اور Pro+ ٹرائل شروع کریں۔
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
ویب پر 14 دن تک Pro+ مفت آزمائیں۔ کارڈ کی ضرورت نہیں۔
Certolizumab pegol کے دیگر تعاملات
- Adenovirus types 4 and 7 live + Certolizumab pegol مانع استعمال
- Bcg intravesical live + Certolizumab pegol مانع استعمال
- Bcg vaccine live + Certolizumab pegol مانع استعمال
- Certolizumab pegol + Influenza virus vaccine quadrivalent intranasal مانع استعمال
- Certolizumab pegol + Measles mumps and rubella vaccine مانع استعمال
- Certolizumab pegol + Measles mumps and rubella vaccine live مانع استعمال
Ciltacabtagene autoleucel کے دیگر تعاملات
اکثر پوچھے جانے والے سوالات
Can I take Certolizumab pegol with Ciltacabtagene autoleucel?
MediHelp rates the interaction as major. Certolizumab pegol and Ciltacabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Certolizumab pegol blocks TNF and causes immunosuppression, while ciltacabtagene autoleucel is given after lymphodepleting chemotherapy and causes prolonged cytopenias and hypogammaglobulinemia. Together they may raise the risk of serious infection. TNF inhibition may also interfere with CAR-T expansion and cytokine biology.
How serious is the interaction between Certolizumab pegol and Ciltacabtagene autoleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting certolizumab pegol around CAR-T infusion unless clearly needed, and consider an alternative. If it cannot be avoided, monitor closely for infection and cytopenias.
What other medicines interact with Certolizumab pegol?
MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.
MediHelp ایپ میں مکمل مونوگراف، خوراک اور تعامل چیکر
MediHelp ایپ میں مکمل حوالہ کھولیں، متعدد ادویات کے تعاملات جانچیں اور خوراک کے ٹولز استعمال کریں۔
